Online citations, reference lists, and bibliographies.
← Back to Search

Enhanced Dissolution Of Celecoxib By Supersaturating Self-emulsifying Drug Delivery System (S-SEDDS) Formulation

W. Song, J. Park, D. W. Yeom, B. K. Ahn, K. Lee, S. Lee, Hye Seung Woo, Y. Choi
Published 2013 · Chemistry, Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
A supersaturating self-emulsifying drug delivery system (S-SEDDS) was prepared and evaluated for enhanced dissolution of celecoxib (CXB), a poorly water-soluble drug. The selected CXB-dissolved SEDDS formulation consisting 10 % Capryol 90 (oil), 45 % Tween 20 (surfactant), and 45 % Tetraglycol (cosurfactant) had the characteristics of small droplet size and great solubility as 208 nm and 556.7 mg/mL in average, respectively. CXB dissolution from SEDDS in simulated gastric fluid was increased to about 20 % for the initial period of 5 min, but decreased to a half level as time elapsed. Thus, precipitation inhibitors were screened to stabilize the supersaturation. The stabilizing effect of Soluplus, an amphiphilic copolymer, was concentration-dependent, revealing the greatest dissolution of approximately 90 % level with delayed drug crystallization by the addition of the copolymer. CXB dissolution from S-SEDDS was pH-independent. We concluded that S-SEDDS formulation would be very useful in the future for developing oral delivery product of poorly water-soluble drugs.
This paper references
10.22037/IJPR.2011.1042
Evaluation of Carbamazepine (CBZ) Supersaturatable Self-Microemulsifying (S-SMEDDS) Formulation In-vitro and In-vivo
Z. Nan (2012)
10.1023/A:1016212804288
A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of in Vitro Drug Product Dissolution and in Vivo Bioavailability
G. Amidon (2004)
10.1007/s11095-011-0558-7
Polymeric Nanoparticles for Increased Oral Bioavailability and Rapid Absorption Using Celecoxib as a Model of a Low-Solubility, High-Permeability Drug
M. Morgen (2011)
10.3109/03639045.2011.619194
In situ intestinal permeability and in vivo absorption characteristics of olmesartan medoxomil in self-microemulsifying drug delivery system
M. Kang (2012)
10.1002/JPS.20906
Combined use of crystalline salt forms and precipitation inhibitors to improve oral absorption of celecoxib from solid oral formulations.
Héctor R Guzmán (2007)
10.1002/JPS.10511
Development of a supersaturable SEDDS (S-SEDDS) formulation of paclitaxel with improved oral bioavailability.
Ping Gao (2003)
10.1016/S0378-5173(00)00610-4
Crystallization of hydrocortisone acetate: influence of polymers.
S. Raghavan (2001)
10.1021/MP0700108
Celecoxib:nicotinamide dissociation: using excipients to capture the cocrystal's potential.
Julius F. Remenar (2007)
10.1211/jpp.58.9.0004
Preparation and evaluation of self‐microemulsifying drug delivery systems (SMEDDS) containing atorvastatin
Hai-rong Shen (2006)
Pharmacokinetics of celecoxib after oral administration in dogs and humans: effect of food and site of absorption.
S. Paulson (2001)
10.1002/BDD.1803
Mechanistic analysis of solute transport in an in vitro physiological two‐phase dissolution apparatus
P. Langguth (2012)
10.1016/S0378-5173(98)00054-4
Formulation design and bioavailability assessment of lipidic self-emulsifying formulations of halofantrine
Shui-Mei Khoo (1998)
10.1081/DDC-120028718
Enhanced Oral Bioavailability of a Poorly Water Soluble Drug PNU‐91325 by Supersaturatable Formulations
Ping Gao (2004)
10.1016/J.IJPHARM.2007.05.060
Nanostructured lipid carrier (NLC) based gel of celecoxib.
M. Joshi (2008)
10.1016/j.ijpharm.2007.12.015
Combination of Pluronic/Vitamin E TPGS as a potential inhibitor of drug precipitation.
Wei-guo Dai (2008)
10.1081/DDC-200047795
Celecoxib-Cyclodextrin Systems: Characterization and Evaluation of In Vitro and In Vivo Advantage
M. Nagarsenker (2005)
10.1016/0378-5173(94)90271-2
Self-emulsifying drug delivery systems (SEDDS) with polyglycolyzed glycerides for improving in vitro dissolution and oral absorption of lipophilic drugs
N. Shah (1994)
10.1002/JPS.20522
Characterization of a novel polymorphic form of celecoxib.
G. W. Lu (2006)
10.1002/jps.21650
Supersaturating drug delivery systems: the answer to solubility-limited oral bioavailability?
J. Brouwers (2009)
10.2165/00003495-200059040-00017
Celecoxib: a review of its use in osteoarthritis, rheumatoid arthritis and acute pain.
D. Clemett (2000)
10.1007/s40005-012-0036-1
Topical formulation of retinyl retinoate employing nanostructured lipid carriers
S. Lee (2012)
10.1007/s40005-012-0029-0
Formulation optimization and in vitro characterization of sertraline loaded self-nanoemulsifying drug delivery system (SNEDDS) for oral administration
M. A. Rahman (2012)
10.1023/A:1016268311867
Lipid Microemulsions for Improving Drug Dissolution and Oral Absorption: Physical and Biopharmaceutical Aspects
P. Constantinides (2004)
Physicians Desk Reference
E. Barnhart (1990)
10.1016/0378-5173(92)90331-U
Liposome leakage and blood circulation: Comparison of adsorbed block copolymers with covalent attachment of PEG
M. Woodle (1992)
10.1248/BPB.27.1993
Formulation design of self-microemulsifying drug delivery systems for improved oral bioavailability of celecoxib.
N. Subramanian (2004)
10.1023/B:PHAM.0000045226.42859.b8
Stability and Solubility of Celecoxib-PVP Amorphous Dispersions: A Molecular Perspective
P. Gupta (2004)
10.1007/s40005-012-0018-3
Preparation and in vitro evaluation of celecoxib-amino acid conjugates as a colon specific prodrug
Y. Lee (2012)
10.1016/S0928-0987(00)00167-6
Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and 'self-microemulsifying' drug delivery systems.
C. Pouton (2000)
10.1016/S0378-5173(01)00685-8
The influence of incubation temperature and surfactant concentration on the interaction between dimyristoylphosphatidylcholine liposomes and poloxamer surfactants.
J. Castile (2001)
10.1002/jps.22750
Supersaturating drug delivery systems: fast is not necessarily good enough.
P. Augustijns (2012)
Preparation and characterization of solid dispersions of carvedilol with PVP K30
A. Sharma (2010)
10.1016/j.ejps.2011.11.025
Soluplus® as an effective absorption enhancer of poorly soluble drugs in vitro and in vivo.
M. Linn (2012)



This paper is referenced by
10.1016/j.nano.2020.102199
A Soluplus/Poloxamer 407-based self-nanoemulsifying drug delivery system for the weakly basic drug carvedilol to improve its bioavailability.
Han Han (2020)
10.3390/pharmaceutics12040365
Current Status of Supersaturable Self-Emulsifying Drug Delivery Systems
Heejun Park (2020)
10.1080/17425247.2016.1218462
From nanoemulsions to self-nanoemulsions, with recent advances in self-nanoemulsifying drug delivery systems (SNEDDS)
Fiza Ur Rehman (2017)
10.3109/10837450.2013.860546
Microbeads: a novel multiparticulate drug delivery technology for increasing the solubility and dissolution of celecoxib
B. Mcdonald (2015)
FORMULATION AND EVALUATION OF SELF EMULSIFYING DRUG DELIVERY SYSTEM (SEDDS) OF IBUPROFEN
D. Saritha (2014)
10.1021/acs.molpharmaceut.5b00622
Pluronic-Functionalized Silica-Lipid Hybrid Microparticles: Improving the Oral Delivery of Poorly Water-Soluble Weak Bases.
Shasha Rao (2015)
10.1016/j.powtec.2020.05.023
Development and characterization of curcumin-loaded solid self-emulsifying drug delivery system (SEDDS) by spray drying using Soluplus® as solid carrier
M. Kamal (2020)
10.1016/j.addr.2018.11.006
Solidification to improve the biopharmaceutical performance of SEDDS: Opportunities and challenges.
P. Joyce (2018)
10.2147/IJN.S136599
Enhanced oral bioavailability of valsartan using a polymer-based supersaturable self-microemulsifying drug delivery system
D. W. Yeom (2017)
10.4155/tde-2019-0053
Polymeric precipitation inhibitor as an effective trigger to convert supersaturated into supersaturable state in vivo.
Dilpreet Singh (2019)
10.1517/17425247.2016.1151872
Polymer-lipid hybrid systems: merging the benefits of polymeric and lipid-based nanocarriers to improve oral drug delivery
Shasha Rao (2016)
10.1016/j.ijpharm.2019.118809
The potential of nanofibers to increase solubility and dissolution rate of the poorly soluble and chemically unstable drug lovastatin.
Saša Kajdič (2019)
10.3390/molecules191220325
Formulation, Characterization, and in Vivo Evaluation of Celecoxib-PVP Solid Dispersion Nanoparticles Using Supercritical Antisolvent Process
Eun-sol Ha (2014)
10.3390/pharmaceutics10030140
Development and Evaluation of a Reconstitutable Dry Suspension to Improve the Dissolution and Oral Absorption of Poorly Water-Soluble Celecoxib
H. Kim (2018)
10.3109/10837450.2015.1055764
Formulation development and systematic optimization of stabilized ziprasidone hydrochloride capsules devoid of any food effect
Sabyasachi Banerjee (2016)
10.1155/2013/848043
Formulation Strategies to Improve the Bioavailability of Poorly Absorbed Drugs with Special Emphasis on Self-Emulsifying Systems
S. Gupta (2013)
10.29090/psa.2020.03.019.0121
Self-nanoemulsifying drug delivery systems (SNEDDS): an advancement technology for oral drug delivery
Boontida Morakul (2020)
10.1016/j.ijpharm.2015.09.011
Role of solid carriers in pharmaceutical performance of solid supersaturable SEDDS of celecoxib.
R. Chavan (2015)
10.1016/j.ijbiomac.2014.09.063
Fabrication and evaluation of celecoxib microparticle surface modified by hydrophilic cellulose and surfactant.
Eun-sol Ha (2015)
10.1016/j.ijpharm.2018.01.045
Development of a new class of sulforaphane-enabled self-emulsifying drug delivery systems (SFN-SEDDS) by high throughput screening: A case study with curcumin.
M. Kamal (2018)
10.3390/ijms160510821
Preparation and in Vivo Evaluation of a Dutasteride-Loaded Solid-Supersaturatable Self-Microemulsifying Drug Delivery System
Min-Soo Kim (2015)
10.1016/J.JDDST.2019.101133
Alendronate-modified polydopamine-coated paclitaxel nanoparticles for osteosarcoma-targeted therapy
Zhao Lei (2019)
10.2174/1573413715666190112122107
Self-microemulsion Technology for Water-insoluble Drug Delivery
B. Yan (2019)
10.1016/j.ijpharm.2014.10.063
Novel semisolid SNEDDS based on PEG-30-dipolyhydroxystearate: development and characterization.
T. Hassan (2014)
10.2147/IJN.S149717
Supersaturable solid self-microemulsifying drug delivery system: precipitation inhibition and bioavailability enhancement
Guilan Quan (2017)
10.1080/10837450.2020.1834580
Supersaturable self-microemulsifying drug delivery system enhances dissolution and bioavailability of telmisartan.
S. Park (2020)
10.1016/j.ijpharm.2014.11.060
Improved oral absorption of dutasteride via Soluplus®-based supersaturable self-emulsifying drug delivery system (S-SEDDS).
D. Lee (2015)
10.1007/s12272-013-0202-7
In situ intestinal permeability and in vivo oral bioavailability of celecoxib in supersaturating self-emulsifying drug delivery system
W. Song (2014)
10.2147/DDDT.S86458
Design of a gelatin microparticle-containing self-microemulsifying formulation for enhanced oral bioavailability of dutasteride
I. Baek (2015)
10.1208/s12249-020-01686-0
Self-Emulsifying Drug Delivery System of Celecoxib for Avoiding Delayed Oral Absorption in Rats with Impaired Gastric Motility
Keisuke Yakushiji (2020)
10.2147/IJN.S83520
Development and optimization of a self-microemulsifying drug delivery system for ator vastatin calcium by using d-optimal mixture design
D. W. Yeom (2015)
10.2147/IJN.S102991
Enhanced dissolution and oral absorption of tacrolimus by supersaturable self-emulsifying drug delivery system
D. R. Lee (2016)
See more
Semantic Scholar Logo Some data provided by SemanticScholar